Heyousheng Biotechnology

Heyousheng Biotechnology is an innovative biotechnology company focusing on primary cells and related reagents and technical services.

ActiveBiopharmaBioTechLife Science

Website

Updated: Feb 17, 2026 ·

About

Heyousheng Biotechnology is an innovative biotechnology company based in Shanghai, China, specializing in the provision of primary cells, related reagents, and technical services. The company focuses on supplying essential biological materials for scientific research and development. Its offerings include various cell types crucial for studies in immunology, virology, and other biomedical fields.

Heyousheng Biotechnology is actively working to accelerate the domestic substitution of primary cells, aiming to provide high-quality, locally sourced alternatives to products traditionally obtained from international suppliers. This strategic focus positions the company as a key player in enhancing the self-sufficiency of China's biotechnology research infrastructure.

Recent News & Mentions

Feb 9, 2026FundingHeyousheng Biotechnology - Seed

Financial History

Heyousheng Biotechnology most recently raised Seed in February 2026.

Total Raised

N/A

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	Seed	Wuxi Guolian Jintou Qiyuan, Wuxi Xidong Industrial Investment Center

Financial History

Total Raised

N/A

Valuation

N/A

Deep Dive

Heyousheng Biotechnology operates as an innovative biotechnology company with a core focus on primary cells, associated reagents, and comprehensive technical services. Headquartered in Shanghai, China, the company serves the scientific research community by providing critical biological components essential for various laboratory studies and experimental protocols.

Its product portfolio includes a range of human primary cells, such as peripheral blood mononuclear cells (PBMCs), Jurkat cells, and THP-1 cells. These cells are frequently utilized in advanced research, including investigations into human cytomegalovirus, anti-HIV-1 activity, and methods for reprogramming human cells into induced pluripotent stem cells. The consistent supply of these high-quality biological materials supports ongoing scientific discovery.

A significant strategic objective for Heyousheng Biotechnology is to accelerate the domestic substitution of primary cells. This initiative aims to reduce reliance on foreign imports by developing and providing domestically produced primary cell products that meet rigorous scientific standards. This effort contributes to strengthening the local biotechnology supply chain and fostering national innovation.

The company's presence within the broader life science ecosystem is recognized, with its inclusion among notable organizations in the Asian life science sector. Its commitment to providing specialized biological products and services underscores its role in supporting academic and industrial research endeavors.

Heyousheng Biotechnology's operations are consistently cited in scientific publications, indicating its role as a reliable supplier of research-grade primary cells. Its contributions facilitate a wide array of biomedical studies, from basic cellular biology to more complex disease mechanisms.

Sources

Frequently Asked Questions

What specific types of primary cells does Heyousheng Biotechnology supply to researchers?

Heyousheng Biotechnology supplies various human primary cells, including peripheral blood mononuclear cells (PBMCs), Jurkat cells, and THP-1 cells, which are utilized in diverse biological and medical research studies.

What strategic market objective is Heyousheng Biotechnology pursuing regarding primary cell products?

The company is focused on accelerating the domestic substitution of primary cells, aiming to replace imported products with high-quality, domestically produced alternatives to enhance national self-sufficiency in biotechnology.

Where is Heyousheng Biotechnology primarily located?

Heyousheng Biotechnology is headquartered in Shanghai, China, as consistently indicated by its supply of cells to various research institutions and its mentions in scientific publications.